BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Juliana de Brito Rangel, Luiz Claudio Santos Thuler, Jorge Francisco da Cunha Pinto. Prevalence of hepatitis C virus infection and its impact on the prognosis of head and neck cancer patientsOral Oncology 2018; 87: 138 doi: 10.1016/j.oraloncology.2018.10.024
2
Charlotte Leduc, Delphine Antoni, Anne Charloux, Pierre-Emmanuel Falcoz, Elisabeth Quoix. Comorbidities in the management of patients with lung cancerEuropean Respiratory Journal 2017; 49(3): 1601721 doi: 10.1183/13993003.01721-2016
3
Stanislas Pol, Anaïs Vallet-Pichard, Olivier Hermine. Extrahepatic cancers and chronic HCV infectionNature Reviews Gastroenterology & Hepatology 2018; 15(5): 283 doi: 10.1038/nrgastro.2017.172
4
Abdelfattah M. Attallah, Mohamed El-Far, Mohamed A. Abdelrazek, Mohamed M. Omran, Ashraf Z. Mahmoud, Hager S. Khalifa, Mohamed M. Ahmed, Ibrahim El-Dosoky. HCV nonstructural protein 4 is associated with aggressiveness features of breast cancerBreast Cancer 2018; 25(3): 297 doi: 10.1007/s12282-017-0829-1
5
Teresa Pollicino, Cristina Musolino, Carlo Saitta, Gianluca Tripodi, Marika Lanza, Giuseppina Raffa, Francesca Casuscelli di Tocco, Chiara Raggi, Maria Consiglia Bragazzi, Adalberto Barbera, Giuseppe Navarra, Pietro Invernizzi, Domenico Alvaro, Giovanni Raimondo. Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinomaOncotarget 2019; 10(39): 3931 doi: 10.18632/oncotarget.27002
6
Harrys A. Torres, Terri Lynn Shigle, Nassim Hammoudi, James T. Link, Felipe Samaniego, Ahmed Kaseb, Vincent Mallet. The oncologic burden of hepatitis C virus infection: A clinical perspectiveCA: A Cancer Journal for Clinicians 2017; 67(5): 411 doi: 10.3322/caac.21403
7
Sara Donà, Daniele Borsetto, Jonathan Fussey, Valeria Biscaro, Elisa Vian, Giacomo Spinato, Anna Menegaldo, Maria Cristina Da Mosto, Roberto Rigoli, Jerry Polesel, Paolo Boscolo-Rizzo. Association between hepatitis C and B viruses and head and neck squamous cell carcinomaJournal of Clinical Virology 2019; 121: 104209 doi: 10.1016/j.jcv.2019.104209
8
Tarek Saadi, Johad Khoury. Is There a Relationship Between Treatment With Direct Antiviral Agents for HCV Infection and the Development of Malignancies?Journal of Clinical Gastroenterology 2018; 52(4): 353 doi: 10.1097/MCG.0000000000000853
9
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_94-1
10
Mitchell L. Shiffman, Nadege T. Gunn. Impact of hepatitis C virus therapy on metabolism and public healthLiver International 2017; 37: 13 doi: 10.1111/liv.13282
11
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and PathogenesisJournal of Clinical Medicine 2017; 6(12): 111 doi: 10.3390/jcm6120111
12
Daniele Borsetto, Jonathan Fussey, Luca Fabris, Luigia Bandolin, Piergiorgio Gaudioso, Veronica Phillips, Jerry Polesel, Paolo Boscolo-Rizzo. HCV infection and the risk of head and neck cancer: A meta-analysisOral Oncology 2020; 109: 104869 doi: 10.1016/j.oraloncology.2020.104869
13
Amy L. Pashler, Benjamin P. Towler, Christopher I. Jones, Sarah F. Newbury. The roles of the exoribonucleases DIS3L2 and XRN1 in human diseaseBiochemical Society Transactions 2016; 44(5): 1377 doi: 10.1042/BST20160107
14
Maya Balakrishnan, Matthew T. Glover, Fasiha Kanwal. Hepatitis C and Risk of Nonhepatic MalignanciesClinics in Liver Disease 2017; 21(3): 543 doi: 10.1016/j.cld.2017.03.009
15
Shuo Wang, Xiao-Zhong Guo, Shi-Xue Xu, Xing-Shun Qi. Risk and treatment of non-hepatic cancers in patients with cirrhosisWorld Chinese Journal of Digestology 2020; 28(15): 655 doi: 10.11569/wcjd.v28.i15.655
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
16
Sirio Fiorino, Salomone Di Saverio, Paolo Leandri, Andrea Tura, Chiara Birtolo, Mauro Silingardi, Dario de Biase, Eli Avisar. The role of matricellular proteins and tissue stiffness in breast cancer: a systematic reviewFuture Oncology 2018; 14(16): 1601 doi: 10.2217/fon-2017-0510
17
D. A. Lioznov, M. S. Nozhkin, O. V. Gorchakova, T. V. Antonova. Characteristics of HCV infection in oncohematological patientsJournal Infectology 2020; 12(1): 91 doi: 10.22625/2072-6732-2020-12-1-91-95
18
Ryan M. Kwok, Tram T. Tran. Management of Cirrhotic Patients After Successful HCV EradicationCurrent Treatment Options in Gastroenterology 2017; 15(2): 305 doi: 10.1007/s11938-017-0134-2
19
A S Samoylov, A Yu Bushmanov, Yu D Udalov, I A Galstyan, V Yu Nugis, M G Kozlova, V A Nikitina, I K Khvostunov, E V Golub. ACUTE MYELOID LEUKEMIA, PROSTATE AND SKIN CANCER IN ACUTE RADIATION SYNDROME SURVIVOR AFTER THE 1986 CHERNOBYL NUCLEAR ACCIDENT: CASE REPORTRadiation Protection Dosimetry 2018; 182(1): 85 doi: 10.1093/rpd/ncy143
20
Manon Allaire, Pierre Nahon, Richard Layese, Valérie Bourcier, Carole Cagnot, Patrick Marcellin, Dominique Guyader, Stanislas Pol, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean‐Pierre Bronowicki, Jean‐Pierre Zarski, Ghassan Riachi, Paul Calès, Jean‐Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Jean‐Frédéric Blanc, Armand Abergel, Lawrence Serfaty, Ariane Mallat, Jean‐Didier Grangé, Pierre Attali, Yannick Bacq, Claire Wartelle, Thông Dao, Dominique Thabut, Christophe Pilette, Christine Silvain, Christos Christidis, Eric Nguyen‐Khac, Brigitte Bernard‐Chabert, David Zucman, Vincent DI Martino, Angela Sutton, Eric Letouzé, Etienne Audureau, Françoise Roudot‐Thoraval. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradicationHepatology 2018; 68(4): 1245 doi: 10.1002/hep.30034
21
Joaquin Burgos, Adria Curran, Stefania Landolfi, Ana Guelar, Lucia Miguel, MaCarmen Dinares, Judith Villar, Jordi Navarro, Javier Hernandez-Losa, Vicenç Falcó. Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected MSMAIDS 2017; 31(9): 1245 doi: 10.1097/QAD.0000000000001433
22
Zuzana Vojtechova, Ruth Tachezy. The Role of miRNAs in Virus-Mediated OncogenesisInternational Journal of Molecular Sciences 2018; 19(4): 1217 doi: 10.3390/ijms19041217
23
Tung‐Hung Su, Tai‐Chung Tseng, Chun‐Jen Liu, Shih‐Wan Chou, Chen‐Hua Liu, Hung‐Chih Yang, Pei‐Jer Chen, Ding‐Shinn Chen, Chi‐Ling Chen, Jia‐Horng Kao. Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancerInternational Journal of Cancer 2020; 147(3): 901 doi: 10.1002/ijc.32840
24
Ameer Abutaleb, Jose Antonio Almario, Saleh Alghsoon, Ji Ae Yoon, Kate Gheysens, Shyam Kottilil, Eleanor Wilson. Higher Levels of Fibrosis in a Cohort of Veterans with Chronic Viral Hepatitis are Associated with Extra-Hepatic CancersJournal of Clinical and Experimental Hepatology 2020;  doi: 10.1016/j.jceh.2020.08.001
25
Romeo-Gabriel Mihăilă. Hepatitis C virus - associated B cell non-Hodgkin's lymphomaWorld Journal of Gastroenterology 2016; 22(27): 6214-6223 doi: 10.3748/wjg.v22.i27.6214
26
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 1671 doi: 10.1007/978-3-319-26956-6_94
27
A. Rivero-Juarez, L. F. Lopez-Cortes, M. Castaño, D. Merino, M. Marquez, M. Mancebo, F. Cuenca-Lopez, P. Jimenez-Aguilar, I. Lopez-Montesinos, S. Lopez-Cardenas, A. Collado, M. A. Lopez-Ruz, M. Omar, F. Tellez, X. Perez-Stachowski, J. Hernandez-Quero, J. A. Girón-Gonzalez, E. Fernandez-Fuertes, A. Rivero. Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategyEuropean Journal of Clinical Microbiology & Infectious Diseases 2017; 36(3): 487 doi: 10.1007/s10096-016-2822-6
28
Daniel Segna, Jean-François Dufour. Other Extrahepatic Manifestations of Hepatitis C Virus Infection (Pulmonary, Idiopathic Thrombocytopenic Purpura, Nondiabetes Endocrine Disorders)Clinics in Liver Disease 2017; 21(3): 607 doi: 10.1016/j.cld.2017.03.014
29
Johad Khoury, George Nassar, Rimma Kramsky, Tarek Saadi. Extrahepatic Malignancies After Treatment with Direct Antiviral Agents for Chronic HCV InfectionJournal of Gastrointestinal Cancer 2020; 51(2): 584 doi: 10.1007/s12029-019-00293-y
30
Zong‐Han Yao, Wei‐Yu Liao, Chao‐Chi Ho, Kuan‐Yu Chen, Jin‐Yuan Shih, Jin‐Shing Chen, Zhong‐Zhe Lin, Chia‐Chi Lin, James Chih‐Hsin Yang, Chong‐Jen Yu. Real‐World Data on Prognostic Factors for Overall Survival in EGFR Mutation‐Positive Advanced Non‐Small Cell Lung Cancer Patients Treated with First‐Line GefitinibThe Oncologist 2017; 22(9): 1075 doi: 10.1634/theoncologist.2016-0331
31
L. Couronné, E. Bachy, S. Roulland, B. Nadel, F. Davi, M. Armand, D. Canioni, J.M. Michot, C. Visco, L. Arcaini, C. Besson, O. Hermine. From hepatitis C virus infection to B-cell lymphomaAnnals of Oncology 2018; 29(1): 92 doi: 10.1093/annonc/mdx635
32
Donald M. Parkin, Lucia Hämmerl, Jacques Ferlay, Eva J. Kantelhardt. Cancer in Africa 2018: The role of infectionsInternational Journal of Cancer 2020; 146(8): 2089 doi: 10.1002/ijc.32538
33
Ahmed Arafa, Ehab S. Eshak, Tarek A. Abdel Rahman, Manal M. Anwar. Hepatitis C virus infection and risk of pancreatic cancer: A meta-analysisCancer Epidemiology 2020; 65: 101691 doi: 10.1016/j.canep.2020.101691
34
George N. Ioannou, Pamela K. Green, Kristin Berry, Solomon A. Graf. Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct‐Acting AntiviralsHepatology Communications 2019; 3(8): 1124 doi: 10.1002/hep4.1389
35
Stanislas Pol, Lucia Parlati, Michel Jadoul. Hepatitis C virus and the kidneyNature Reviews Nephrology 2019; 15(2): 73 doi: 10.1038/s41581-018-0081-8
36
Gema Lledó, Laura Benítez-Gutiérrez, Ana Arias, Silvia Requena, Valentín Cuervas-Mons, Carmen de Mendoza. Benefits of hepatitis C cure with antivirals: why test and treat?Future Microbiology 2019; 14(5): 425 doi: 10.2217/fmb-2019-0041
37
Nader N. Massarweh, Hashem B. El-Serag. Epidemiology of Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaCancer Control 2017; 24(3): 107327481772924 doi: 10.1177/1073274817729245
38
Elisa Barone, Alda Corrado, Federica Gemignani, Stefano Landi. Environmental risk factors for pancreatic cancer: an updateArchives of Toxicology 2016; 90(11): 2617 doi: 10.1007/s00204-016-1821-9